Massimiliano Cergnul

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

Joris van de Haar, Xuhui Ma, Salo Ooft et al. · Nature Medicine · 2023 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non–small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study

Andrea Luciani, Antonio Marra, Luca Toschi et al. · Clinical Lung Cancer · 2020 · 28 citations

Medicine, Immunology, Oncology +16

Capecitabine in Breast Cancer: The Issue of Cardiotoxicity During Fluoropyrimidine Treatment

L. Molteni, I. Rampinelli, Massimiliano Cergnul et al. · The Breast Journal · 2010 · 26 citations

Medicine, Oncology, Pharmacology +17

Bcl-6 protein expression, and not the germinal centre immunophenotype, predicts favourable prognosis in a series of primary nodal diffuse large B-cell lymphomas: A single centre experience

Silvia Uccella, Claudia Placidi, Silvia Marchet et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 22 citations

Medicine, Oncology, Pathology +17

Lycopene minimizes skin toxicity and oxidative stress in patients treated with panitumumab-containing therapy for metastatic colorectal cancer

Mauro Moroni, M Pirovano, Silvia Brugnatelli et al. · Journal of Functional Foods · 2021 · 13 citations · Full text

Medicine, Oncology, Pharmacology +17